Skip to main content
Caplight Logo









MicroMGx

MicroMGx

Private
Evanston, IllinoisHealthcare & Life Scienceshttps://micromgx.com

Last Round

Accelerator

Jan 9, 2025

Total Funding Raised

$874,508

Company Overview

MicroMGx is a life sciences company that provides a metabologenomics platform to accelerate the discovery of novel natural products for pharmaceutical, agricultural, and animal health applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

natural product discoverydrug discoverybioinformaticsmetabologenomicsmicrobial librarybiotech discovery platformsmall molecule discoverycontract researchCROcomputational biologydrug discovery partnerin silico drug discoverybiotech R&DAI-enabled drug discoverydrug discovery AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MicroMGx Comparables

Compare MicroMGx with similar companies based on industry and business-model similarity.

MicroMGx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Adapsyn Bioscience
87%
NAICONS Srl
84%
Clue Genetics Inc.
84%

MicroMGx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 9, 2025
CrowdfundingApr 21, 2023
AcceleratorOct 20, 2022
GrantJan 6, 2017

Key People

Founding team and executive leadership

Jack Kloeber

Chief Executive Officer

Executive Team

MicroMGx Investors

Notable investors and investment history

MicroMGx investors
InvestorRounds
HudsonAlpha Institute for BiotechnologyAccelerator
gener8torAccelerator
NIH RADxGrant
AgLaunch AcceleratorAccelerator
NetcapitalCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors grew 54% MoM, reaching 2.5K.

  • Mar 1, 2026

    Monthly visitors grew 539% MoM, from 252 to 1.6K.

MicroMGx Filings

Explore SEC and related filing metadata, where available.

MicroMGx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MicroMGx's valuation, stock price, and market status.

Is MicroMGx a public or private company?

MicroMGx is a private company.

What is the current stock price of MicroMGx?

MicroMGx is a private company, so its shares have no public market price. Caplight tracks MicroMGx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MicroMGx worth (valuation)?

Valuation information for MicroMGx is not publicly available.

Can I buy MicroMGx stock?

MicroMGx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MicroMGx's last funding round?

MicroMGx's most recent funding round was Accelerator on January 9, 2025.

Who are the main investors in MicroMGx?

Key investors in MicroMGx include HudsonAlpha Institute for Biotechnology, gener8tor, NIH RADx, AgLaunch Accelerator, Netcapital.

Will MicroMGx IPO soon?

No public IPO plans have been announced for MicroMGx.

How can I track MicroMGx secondary market activity?

Caplight tracks bids, offers, and trades in MicroMGx's shares on secondary markets.

Firmographic Details

HeadquartersEvanston, Illinois
Employee Range4
Year Founded2015
Last FundingJan 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?